Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Interleukin Genetics
About
Interleukin Genetics develops genetic tests for the personalized health market.
- Waltham,Massachusetts,United States
- 1 - 10
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $5M
- Industries
- Biotechnology,Genetics,Health Care,Medical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 1 - 10
- Operating Status
- Close
- Stock Symbol
- otcqb:ILIU
Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 10, 2016 | Post-IPO Equity | $5.59M | — | — | — | Detail |
| Dec 23, 2014 | Post-IPO Debt | $5M | 1 |
Horizon Technology Finance
|
— | Detail |
| Dec 23, 2014 | Post-IPO Equity | $5M | 2 | — | — | Detail |
| May 20, 2013 | Post-IPO Equity | $12M | 1 | — | — | Detail |
| Jul 2, 2012 | Post-IPO Equity | $3M | 1 |
Delta Dental of Oklahoma
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Horizon Technology Finance
|
Yes | Post-IPO Debt |
|
Delta Dental of Oklahoma
|
Yes | Post-IPO Equity |
Bay City Capital
|
— | Post-IPO Equity |
New Enterprise Associates
|
— | Post-IPO Equity |
Alticor Corporate Enterprises
|
— | Post-IPO Equity |
Employee Profiles
Acquisition
Interleukin Genetics has acquired 1 organizations. Their most recent acquisition was Alan James Group on Aug 17, 2006. They acquired Alan James Group for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 17, 2006
|
Consumer Goods | — | — | Detail |
